tiprankstipranks
Calidi Biotherapeutics (CLDI)
XASE:CLDI
US Market
CLDI
Calidi Biotherapeutics
RESEARCH TOOLSreports

Calidi Biotherapeutics (CLDI) Financial Statements

Compare
362 Followers

Calidi Biotherapeutics Financial Overview

Calidi Biotherapeutics's market cap is currently $2.07M. The company's EPS TTM is $; its P/E ratio is -0.36; Calidi Biotherapeutics is scheduled to report earnings on March 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 45.00K$ 449.00K$ 0.00
Gross Profit$ 0.00$ -1.26M$ -229.00K$ 355.00K$ 0.00
Operating Income$ -21.78M$ -28.99M$ -23.13M$ -10.48M$ -6.77M
EBITDA$ -19.73M$ -24.20M$ -25.00M$ -9.45M$ -6.67M
Net Income$ -22.14M$ -29.22M$ -25.43M$ -10.93M$ -7.94M
Balance Sheet
Cash & Short-Term Investments$ 9.59M$ 2.05M$ 372.00K$ 2.14M$ 420.00K
Total Assets$ 14.18M$ 10.02M$ 2.60M$ 3.39M$ 1.85M
Total Debt$ 7.04M$ 7.24M$ 5.99M$ 5.18M$ 11.72M
Net Debt$ -2.56M$ 5.19M$ 5.62M$ 3.04M$ 11.30M
Total Liabilities$ 12.21M$ 18.25M$ 53.04M$ 26.00M$ 24.33M
Stockholders' Equity$ 1.53M$ -8.23M$ -50.44M$ -22.61M$ -22.48M
Cash Flow
Free Cash Flow$ -19.71M$ -27.57M$ -13.64M$ -7.98M$ -5.18M
Operating Cash Flow$ -19.69M$ -26.98M$ -13.21M$ -7.77M$ -4.83M
Investing Cash Flow$ -16.00K$ -478.00K$ -494.00K$ -215.00K$ -388.00K
Financing Cash Flow$ 27.36M$ 29.04M$ 12.09M$ 9.81M$ 4.70M
Currency in USD

Calidi Biotherapeutics Earnings and Revenue History

Income Statement >

Calidi Biotherapeutics Debt to Assets

Balance Sheet >

Calidi Biotherapeutics Cash Flow

Cash Flow >

Calidi Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >